This Biotech with Breakout MS Drug Draws Big Investment
A breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
This article explains typical reasons you may not be able to link a bank account to a crypto exchange and how to troubleshoot them.
23,159 articlesA breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
A rare look at how a mega-charity stewards billions in investments, the risk of concentration, and practical steps yo...
A rising fintech stock year story shows profits climbing while a major fund trims nearly $300M from its stake. The mo...
Through March 21, 2026, VT is down less than 1% year-to-date while SPY slides about 3%, signaling a shift toward glob...
An investor group disclosed a $3.5 million stake in Avantor as the stock slipped more than half. This article breaks ...
A pullback in AbbVie has some investors asking if the stock looks like a bargain. This guide explains why that view m...
Astera Labs sits at a pivotal point in the data center supply chain. This article breaks down why the stock could ris...
A patient investor could see a multi-year rebound in a little-known robotics stock. Learn the growth drivers, how to ...
Firms are tightening AI requirements across industries, pushing workers to upskill quickly. This article breaks down ...
Tesla is recalling more than 218,000 cars and SUVs due to a rearview camera delay that could impair reversing visibil...
Rhode Island’s small firms drive growth, jobs, and innovation. This article explains how a high-earner surtax would a...
Axsome Therapeutics rode a powerful April rally driven by Auvelity performance and pipeline momentum. This article br...